Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz  Is a corresponding author
  11. Marina Mikhaylova  Is a corresponding author
  1. Humboldt-Universität zu Berlin, Institute of Biology, Germany
  2. European Molecular Biology Laboratory, Germany
  3. University Medical Centre Hamburg-Eppendorf, Germany
  4. Korea Advanced Institute of Science and Technology, Republic of Korea
  5. Washington State University, United States
  6. Leibniz-Institute for Neurobiology, Germany

Abstract

Members of the SH3- and ankyrin-rich repeat (SHANK) protein family are considered as master scaffolds of the post-synaptic density of glutamatergic synapses. Several missense mutations within the canonical SHANK3 isoform have been proposed as causative for the development of autism spectrum disorders (ASDs). However, there is a surprising paucity of data linking missense mutation-induced changes in protein structure and dynamics to the occurrence of ASD-related synaptic phenotypes. In this proof-of-principle study, we focus on two ASD-associated point mutations, both located within the same domain of SHANK3 and demonstrate that both mutant proteins indeed show distinct changes in secondary and tertiary structure as well as higher conformational fluctuations. Local and distal structural disturbances result in altered synaptic targeting and changes of protein turnover at synaptic sites in rat primary hippocampal neurons.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Michael Bucher

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Stephan Niebling

    Molecular Biophysics and High-Throughput Crystallization, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Yuhao Han

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmitry Molodenskiy

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5954-4294
  5. Fatemeh Hassani Nia

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Hans-Jürgen Kreienkamp

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8871-9970
  7. Dmitri Svergun

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Eunjoon Kim

    Center for Synaptic Brain Dysfunctions, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  9. Alla S Kostyukova

    The Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Michael R Kreutz

    RG Neuroplasticity, Leibniz-Institute for Neurobiology, Magdeburg, Germany
    For correspondence
    michael.kreutz@zmnh.uni-hamburg.de
    Competing interests
    The authors declare that no competing interests exist.
  11. Marina Mikhaylova

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    For correspondence
    marina.mikhaylova@hu-berlin.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7646-1346

Funding

Deutsche Forschungsgemeinschaft (MI1923/1-2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (FOR2419 TP2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (EXC-2049-390688087)

  • Marina Mikhaylova

Leibniz-Gemeinschaft (Neurotranslation)

  • Michael R Kreutz

Deutscher Akademischer Austauschdienst (Research Stays for University Academics and Scientists Award)

  • Alla S Kostyukova

Hamburg Landesforschungsförderung (LFF-FV76)

  • Marina Mikhaylova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Inna Slutsky, Tel Aviv University, Israel

Ethics

Animal experimentation: All animal experiments were carried out in accordance with the European Communities Council Directive (2010/63/EU) and the Animal Welfare Law of the Federal Republic of Germany (Tierschutzgesetz der Bundesrepublik Deutschland, TierSchG) approved by the local authorities of the city-state Hamburg (Behörde für Gesundheit und Verbraucherschutz, Fachbereich Veterinärwesen) and the animal care committee of the University Medical Center Hamburg-Eppendorf.

Version history

  1. Received: December 30, 2020
  2. Accepted: May 1, 2021
  3. Accepted Manuscript published: May 4, 2021 (version 1)
  4. Version of Record published: June 1, 2021 (version 2)

Copyright

© 2021, Bucher et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,419
    views
  • 415
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz
  11. Marina Mikhaylova
(2021)
Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses
eLife 10:e66165.
https://doi.org/10.7554/eLife.66165

Share this article

https://doi.org/10.7554/eLife.66165

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Bohan Zhu, Richard I Ainsworth ... Javier González-Maeso
    Research Article

    Genome-wide association studies have revealed >270 loci associated with schizophrenia risk, yet these genetic factors do not seem to be sufficient to fully explain the molecular determinants behind this psychiatric condition. Epigenetic marks such as post-translational histone modifications remain largely plastic during development and adulthood, allowing a dynamic impact of environmental factors, including antipsychotic medications, on access to genes and regulatory elements. However, few studies so far have profiled cell-specific genome-wide histone modifications in postmortem brain samples from schizophrenia subjects, or the effect of antipsychotic treatment on such epigenetic marks. Here, we conducted ChIP-seq analyses focusing on histone marks indicative of active enhancers (H3K27ac) and active promoters (H3K4me3), alongside RNA-seq, using frontal cortex samples from antipsychotic-free (AF) and antipsychotic-treated (AT) individuals with schizophrenia, as well as individually matched controls (n=58). Schizophrenia subjects exhibited thousands of neuronal and non-neuronal epigenetic differences at regions that included several susceptibility genetic loci, such as NRG1, DISC1, and DRD3. By analyzing the AF and AT cohorts separately, we identified schizophrenia-associated alterations in specific transcription factors, their regulatees, and epigenomic and transcriptomic features that were reversed by antipsychotic treatment; as well as those that represented a consequence of antipsychotic medication rather than a hallmark of schizophrenia in postmortem human brain samples. Notably, we also found that the effect of age on epigenomic landscapes was more pronounced in frontal cortex of AT-schizophrenics, as compared to AF-schizophrenics and controls. Together, these data provide important evidence of epigenetic alterations in the frontal cortex of individuals with schizophrenia, and remark for the first time on the impact of age and antipsychotic treatment on chromatin organization.

    1. Neuroscience
    Aedan Yue Li, Natalia Ladyka-Wojcik ... Morgan Barense
    Research Article

    Combining information from multiple senses is essential to object recognition, core to the ability to learn concepts, make new inferences, and generalize across distinct entities. Yet how the mind combines sensory input into coherent crossmodal representations - the crossmodal binding problem - remains poorly understood. Here, we applied multi-echo fMRI across a four-day paradigm, in which participants learned 3-dimensional crossmodal representations created from well-characterized unimodal visual shape and sound features. Our novel paradigm decoupled the learned crossmodal object representations from their baseline unimodal shapes and sounds, thus allowing us to track the emergence of crossmodal object representations as they were learned by healthy adults. Critically, we found that two anterior temporal lobe structures - temporal pole and perirhinal cortex - differentiated learned from non-learned crossmodal objects, even when controlling for the unimodal features that composed those objects. These results provide evidence for integrated crossmodal object representations in the anterior temporal lobes that were different from the representations for the unimodal features. Furthermore, we found that perirhinal cortex representations were by default biased towards visual shape, but this initial visual bias was attenuated by crossmodal learning. Thus, crossmodal learning transformed perirhinal representations such that they were no longer predominantly grounded in the visual modality, which may be a mechanism by which object concepts gain their abstraction.